Good morning :)
Place Order
Add to Watchlist

Rossari Biotech Ltd

ROSSARI Share Price

700.600.60% (-4.20)
High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP

With a market cap of ₹3,878 cr, stock is ranked 872

Stock is 2.30x as volatile as Nifty

ROSSARI Stock Scorecard

Performance

Low

Hasn't fared well - amongst the low performers

Valuation

High

Seems to be overvalued vs the market average

Growth

Low

Lagging behind the market in financials growth

Profitability

High

Showing good signs of profitability & efficiency

Entry point

Good

The stock is underpriced and is not in the overbought zone

Red flags

Low

No red flag found

How to use scorecard? Learn more

With a market cap of ₹3,878 cr, stock is ranked 872

Stock is 2.30x as volatile as Nifty

ROSSARI Performance & Key Metrics

ROSSARI Performance & Key Metrics

No LabelNo LabelPB RatioPB RatioDividend YieldDiv. Yield
28.443.270.07%
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
27.933.471.60%

ROSSARI Analyst Ratings & Forecast

Detailed Forecast Detailed Forecast 
100%
Analysts have suggested that investors can buy this stock

from 4 analysts

Price Upside

Earnings Growth

Rev. Growth

See Detailed Forecast

ROSSARI Company Profile

Rossari Biotech is engaged in business of textile and specialty chemical manufacturing.

Investor Presentation

View older View older 

Apr 26, 2025

PDF
View Older Presentations

ROSSARI Similar Stocks (Peers)

Compare with peers Compare with peers 

ROSSARI Similar Stocks (Peers)

Compare with peers Compare with peers 
PE Ratio
68.70
68.70
1Y Return
6.04%
6.04%
Buy Reco %
55.56
55.56
PE Ratio
86.00
86.00
1Y Return
36.19%
36.19%
Buy Reco %
62.96
62.96
PE Ratio
50.31
50.31
1Y Return
2.82%
2.82%
Buy Reco %
83.33
83.33
PE Ratio
38.18
38.18
1Y Return
23.29%
23.29%
Buy Reco %
50.00
50.00
PE Ratio
49.07
49.07
1Y Return
36.05%
36.05%
Buy Reco %
70.59
70.59
Compare with Peers

ROSSARI Sentiment Analysis

ROSSARI Sentiment Analysis

New
Crisp summary & key insights to decode earnings calls instantly

ROSSARI Stock Summary · May 2025

The company has achieved a remarkable 13.6% year-over-year revenue growth, bolstered by a diversified portfolio and strategic investments in emerging verticals, despite facing rising operational costs and margin pressures. With a focus on sustainable solutions and innovation, it is enhancing its market position as a one-stop shop for major clients, while navigating challenges in raw material pricing and geopolitical uncertainties. The successful commercialization of new product platforms, particularly in the HPPC and Buzil segments, is expected to drive future profitability, although negative EBITDA remains a concern in the short term. As the company expands its production capabilities and integrates backward, it aims to stabilize costs and achieve targeted EBITDA margins, positioning itself for long-term growth amidst a dynamic market landscape.

ROSSARI Stock Growth Drivers
ROSSARI Stock Growth Drivers
6
  • Strong Financial Performance

    In FY25, the company reported a revenue from operations of Rs. 2,080 crore, marking a

  • Expansion and Investment Initiatives

    The company is advancing multiple expansion projects, with ongoing expansions at Dahej and Unitop on

ROSSARI Stock Challenges
ROSSARI Stock Challenges
6
  • Declining EBITDA Margins

    The company has reported a decline in EBITDA margins, with the margin for Q4 FY25

  • Negative Performance in Buzil Segment

    The Buzil segment is experiencing negative EBITDA despite an increase in revenue, indicating that the

ROSSARI Forecast

ROSSARI Forecasts

Price

Revenue

Earnings

ROSSARI

ROSSARI

Income

Balance Sheet

Cash Flow

ROSSARI Income Statement

ROSSARI Income Statement

Industry refers to the sub-sector this company belongs to.
Higher than Industry Revenue Growth
A higher-than-industry revenue growth represents increased potential for the company to increase their market share

Over the last 5 years, revenue has grown at a yearly rate of 28.13%, vs industry avg of 11.02%

Increasing Market Share
Market share is the percentage of an industry's total sales going to a particular company. It gives a general idea of the size of a company v/s its competitors

Over the last 5 years, market share increased from 1.13% to 2.21%

Higher than Industry Net Income
Net income is equal to net earnings (profit) less expenses. This number is an important measure of how profitable the company is

Over the last 5 years, net income has grown at a yearly rate of 15.89%, vs industry avg of 7.7%

Loading...

Financial YearFY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025TTM
Total Revenue517.13603.81718.471,496.511,662.321,838.182,085.282,085.28
Raw Materialssubtract355.23369.26470.621,128.081,183.961,357.041,464.411,815.21
Power & Fuel Costsubtract1.261.742.4011.9220.4023.3025.91
Employee Costsubtract27.5237.2141.9867.9398.62103.13132.33
Selling & Administrative Expensessubtract38.0750.7936.7037.9358.8961.5497.60
Operating & Other expensessubtract16.5936.5734.1153.6771.0035.7994.96
Depreciation/Amortizationsubtract12.1916.8522.8348.0662.9360.3967.0767.07
Interest & Other Itemssubtract2.883.562.9912.6622.3219.3717.8117.81
Taxes & Other Itemssubtract17.7122.5826.6238.6036.9646.9348.8148.80
EPS9.4413.1615.6218.2619.4623.6824.6624.64
DPS0.000.500.500.500.500.500.500.50
Payout ratio0.000.040.030.030.030.020.020.02

ROSSARI Company Updates

Annual Report and Investor Presentation updates mentioned here are as reported by the company to the exchange
FY 2025FY 2025

Annual report

PDF

Investor Presentation

Apr 26PDF
Jan 22PDF
Oct 20PDF
Oct 20PDF
FY 2024FY 2024

Annual report

PDF

Investor Presentation

Jul 29PDF
FY 2023FY 2023

Annual report

PDF

Investor Presentation

Apr 30PDF
Feb 5PDF
Feb 5PDF
+2 more
FY 2022FY 2022

Annual report

PDF
FY 2021FY 2021

Annual report

PDF
 

ROSSARI Stock Peers

ROSSARI Past Performance & Peer Comparison

ROSSARI Past Performance & Peer Comparison

Comparing 3 stocks from 
MaterialsSpecialty Chemicals

Loading...

StockPE RatioPE RatioPB RatioPB RatioDiv. YieldDividend Yield
Rossari Biotech Ltd28.443.270.07%
Gujarat Fluorochemicals Ltd68.706.320.09%
Navin Fluorine International Ltd86.009.450.14%
Vinati Organics Ltd50.318.280.38%

ROSSARI Stock Price Comparison

Compare ROSSARI with any stock or ETF
Compare ROSSARI with any stock or ETF
ROSSARI
Loading...

ROSSARI Holdings

ROSSARI Shareholdings

ROSSARI Promoter Holdings Trend

ROSSARI Promoter Holdings Trend

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

ROSSARI Institutional Holdings Trend

ROSSARI Institutional Holdings Trend

Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.

In last 3 months, retail holding in the company has almost stayed constant

Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock

In last 3 months, foreign institutional holding of the company has almost stayed constant

Tickertape Separator

ROSSARI Shareholding Pattern

ROSSARI Shareholding Pattern

Retail and OthersForeign InstitutionsOther Domestic InstitutionsMutual FundsTotal Promoter Holding68.18%13.29%4.30%3.98%10.25%

Jun 2024

Sep 2024

Dec 2024

Mar 2025

ROSSARI Shareholding History

ROSSARI Shareholding History

Dec '23MarJunSepDec '24Mar4.14%4.03%3.83%3.74%3.74%3.98%

Mutual Funds Invested in ROSSARI

Mutual Funds Invested in ROSSARI

No mutual funds holding trends are available

Top 5 Mutual Funds holding Rossari Biotech Ltd




Funds (Top 5)Market-cap heldWeight3M holding changePortfolio rank
(3M change)
3.5682%0.39%-0.01%59/71 (-2)
3.0915%0.46%0.02%31/64 (0)
1.9234%0.57%-0.05%91/106 (-3)

Compare 3-month MF holding change on Screener

ROSSARI Insider Trades & Bulk Stock Deals

ROSSARI Insider Trades & Bulk Stock Deals

Hmm, looks like there hasn't been any net deal activity in the last 6 months

smallcases containing ROSSARI stock

smallcases containing ROSSARI stock

Looks like this stock is not in any smallcase yet.

ROSSARI Events

ROSSARI Events

ROSSARI Dividend Trend

No Dividend Cuts
Dividends are the portion of earnings that a company distributes to all its shareholders every year

ROSSARI has increased or maintained dividend levels over the last 5 years

Dividend Yield
Dividend return is one of the most important things to be considered while investing for long term. It is the additional return on top of what investors earn through price appreciation

Current dividend yield is 0.07%. An investment of ₹1,000 in the stock is expected to generate dividend of ₹0.71 every year

Dividends

Corp. Actions

Announcements

Legal Orders

ROSSARI Dividend Trend

No Dividend Cuts
Dividends are the portion of earnings that a company distributes to all its shareholders every year

ROSSARI has increased or maintained dividend levels over the last 5 years

Dividend Yield
Dividend return is one of the most important things to be considered while investing for long term. It is the additional return on top of what investors earn through price appreciation

Current dividend yield is 0.07%. An investment of ₹1,000 in the stock is expected to generate dividend of ₹0.71 every year

ROSSARI Upcoming Dividends

ROSSARI Upcoming Dividends

No upcoming dividends are available

ROSSARI Past Dividends

ROSSARI Past Dividends

Cash Dividend

Ex DateEx DateJun 20, 2025

Final
Final | Div/Share: ₹0.50

Dividend/Share

0.50

Ex DateEx Date

Jun 20, 2025

Cash Dividend

Ex DateEx DateAug 16, 2024

Final
Final | Div/Share: ₹0.50

Dividend/Share

0.50

Ex DateEx Date

Aug 16, 2024

Cash Dividend

Ex DateEx DateMay 24, 2023

Final
Final | Div/Share: ₹0.50

Dividend/Share

0.50

Ex DateEx Date

May 24, 2023

Cash Dividend

Ex DateEx DateJul 7, 2022

Final
Final | Div/Share: ₹0.50

Dividend/Share

0.50

Ex DateEx Date

Jul 7, 2022

Cash Dividend

Ex DateEx DateSep 8, 2021

Final
Final | Div/Share: ₹0.50

Dividend/Share

0.50

Ex DateEx Date

Sep 8, 2021

ROSSARI Stock News & Opinions

ROSSARI Stock News & Opinions

Corporate
Rossari Biotech schedules AGM

Rossari Biotech announced that the 16th Annual General Meeting(AGM) of the company will be held on 30 June 2025.Powered by Capital Market - Live

1 month agoCapital Market - Live
Spotlight
Rossari Biotech Q4 PAT rises to Rs 34 crore in FY25

However, revenue from operations jumped 22.60% to Rs 579.56 crore in the fourth quarter of FY25 as against Rs 472.72 crore posted in the corresponding quarter last year. Profit before tax stood at Rs 47.71 crore in the quarter ended 31 March 2025, up 4.69% as against Rs 45.57 crore recorded in Q4 FY24. Total expenses rose 24.79% to Rs 533.79 crore during the quarter. Cost of material consumed stood at Rs 369.77 crore (up 21.65% YoY), employee benefit expenses stood at Rs 35.48 crore (up 41.69%), and finance costs were at Rs 5.50 crore (up 118.25% YoY) during the period under review. EBITDA dropped 9.27% to Rs 69.5 crore in the quarter ended 31 March 2025 as compared to Rs 63.6 crore posted in the same quarter the previous year. EBITDA margin reduced to 12% in Q4 FY25 as against 13.5% recorded in Q4 FY24. On a full-year basis, the company's consolidated net profit rose 4.35% to Rs 136.38 crore on 13.64% rise in revenue to Rs 2,080.29 crore in FY25 over FY24. Commenting on the performance, in a joint statement, Edward Menezes, promoter & executive chairman, and Sunil Chari, promoter & managing director, said, 'We concluded the year with a steady performance, navigating a soft and evolving operating environment. Revenues grew by 14% driven by healthy export momentum and resilient volumes across key categories. The HPPC segment remained the primary growth driver, supported by deeper market penetration and strong traction across agrochemicals, personal care, institutional and consumer business. The TSC and AHN segments recorded modest revenue growth, contributing positively to the overall performance. We remain optimistic about their medium-to-long-term potential, supported by ongoing portfolio optimization efforts Export markets continued to perform well during the year, validating our strategic investments in global partnerships and differentiated solutions. We are also encouraged by the growing momentum in emerging verticals such as institutional cleaning and B2C businesses, which reflect our ability to build scalable, value-added platforms aligned with evolving customer needs. We continue to invest in capacity enhancement to strengthen our growth foundation and are pleased to announce an additional capex of Rs 97 crore for expansions at our subsidiaries, Unitop Chemicals and Tristar Intermediates, along with Rs 95 crore at Rossari Biotech. These projects, expected to be commissioned in a phased manner by Q4 FY26, are aimed at supporting growth across our key chemistries, improving operational efficiency, and enhancing supply reliability. Our previously announced expansion projects are progressing well, with commissioning expected by Q2 FY26. With these capacity additions, we are well-positioned to meet growing demand across end-user industries. Looking ahead, we remain focused on delivering sustainable, profitable growth through sharp execution, customer-centric innovation, and strategic diversification. Supported by a strong balance sheet, an agile business model, and a growing global footprint, we are confident in our ability to maintain healthy growth momentum in the coming years.' Meanwhile, the company's board has declared a final dividend of Rs 0.50 per share each for the financial year ended 31 March 2025, which shall be paid/dispatched within 10 working days from the conclusion of the 16th Annual General Meeting, subject to approval of the members of the company. Rossari Biotech is a specialty chemical manufacturer and offers tailor-made solutions for home, personal care and performance chemicals (HPPC), textile speciality chemicals and animal health and nutrition (AHN). The counter shed 0.79% to Rs 693.25 on the BSE. Powered by Capital Market - Live

2 months agoCapital Market - Live
Corporate
Board of Rossari Biotech recommends final dividend

Rossari Biotech announced that the Board of Directors of the Company at its meeting held on 25 April 2025, inter alia, have recommended the final dividend of Rs 0.5 per equity Share (i.e. 25%) , subject to the approval of the shareholders.Powered by Capital Market - Live

2 months agoCapital Market - Live
Earnings
Rossari Biotech consolidated net profit rises 0.91% in the March 2025 quarter

Net profit of Rossari Biotech rose 0.91% to Rs 34.44 crore in the quarter ended March 2025 as against Rs 34.13 crore during the previous quarter ended March 2024. Sales rose 22.60% to Rs 579.56 crore in the quarter ended March 2025 as against Rs 472.72 crore during the previous quarter ended March 2024. For the full year,net profit rose 4.35% to Rs 136.38 crore in the year ended March 2025 as against Rs 130.69 crore during the previous year ended March 2024. Sales rose 13.64% to Rs 2080.29 crore in the year ended March 2025 as against Rs 1830.56 crore during the previous year ended March 2024. ParticularsQuarter EndedYear EndedMar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var. Sales579.56472.72 23 2080.291830.56 14 OPM %11.9913.45 -12.7413.64 - PBDT65.9361.64 7 252.26238.01 6 PBT47.7145.57 5 185.19177.62 4 NP34.4434.13 1 136.38130.69 4 Powered by Capital Market - Live

2 months agoCapital Market - Live
Earnings
Rossari Biotech standalone net profit rises 23.65% in the March 2025 quarter

Net profit of Rossari Biotech rose 23.65% to Rs 32.36 crore in the quarter ended March 2025 as against Rs 26.17 crore during the previous quarter ended March 2024. Sales rose 35.96% to Rs 426.65 crore in the quarter ended March 2025 as against Rs 313.80 crore during the previous quarter ended March 2024. For the full year,net profit rose 15.14% to Rs 114.74 crore in the year ended March 2025 as against Rs 99.65 crore during the previous year ended March 2024. Sales rose 19.01% to Rs 1431.63 crore in the year ended March 2025 as against Rs 1202.91 crore during the previous year ended March 2024. ParticularsQuarter EndedYear EndedMar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var. Sales426.65313.80 36 1431.631202.91 19 OPM %12.2313.30 -13.0113.41 - PBDT51.5141.33 25 182.39158.33 15 PBT43.8534.75 26 154.70134.14 15 NP32.3626.17 24 114.7499.65 15 Powered by Capital Market - Live

2 months agoCapital Market - Live
Corporate
Rossari Biotech to announce Quarterly Result

Rossari Biotech will hold a meeting of the Board of Directors of the Company on 25 April 2025.Powered by Capital Market - Live

2 months agoCapital Market - Live
Spotlight
Rossari Biotech slides after PAT tumble 8% YoY to Rs 32 cr in Q3 FY25

However, revenue from operations jumped 10.55% to Rs 512.73 crore in the third quarter of FY25 as against Rs 463.77 crore posted in the corresponding quarter last year. Profit before tax stood at Rs 42.38 crore in the quarter ended 31 December 2024, down 11.30% as against Rs 47.78 crore recorded in Q3 FY24. Total expenses advanced 12.32% to Rs 471.23 crore during the quarter. Cost of material consumed stood at Rs 321.48 crore (down 17.78% YoY), employee benefit expenses stood at Rs 35.69 crore (up 37.07%) while finance cost was at Rs 4.94 crore (up 14.35% YoY), during the period under review. On nine-month basis, the company's standalone net profit rose 5.56% to Rs 101.93 crore on 10.52% increase in revenue to Rs 1,500.7 crore in 9M FY25 over 9M FY24. Rossari Biotech is a specialty chemical manufacturer and offers tailor-made solutions for home, personal care and performance chemicals (HPPC), textile speciality chemicals and animal health and nutrition (AHN). Powered by Capital Market - Live

5 months agoCapital Market - Live
Earnings
Rossari Biotech consolidated net profit declines 7.82% in the December 2024 quarter

Net profit of Rossari Biotech declined 7.82% to Rs 31.70 crore in the quarter ended December 2024 as against Rs 34.39 crore during the previous quarter ended December 2023. Sales rose 10.56% to Rs 512.73 crore in the quarter ended December 2024 as against Rs 463.77 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var. Sales512.73463.77 11 OPM %12.6313.73 - PBDT60.7062.87 -3 PBT42.3847.78 -11 NP31.7034.39 -8 Powered by Capital Market - Live

5 months agoCapital Market - Live
Corporate
Rossari Biotech shifts registered office

The board of Rossari Biotech at its meeting held on 21 January 2025 has approved change in registered office from 201 A - B, 2nd Floor, Akruti Corporate Park, L.B.S Marg, Next to GE Gardens, Kanjurmarg (W), Mumbai - 400078 to Rossari House, Golden Oak, LBS Marg, Surya Nagar, Opp. Mahindra Showroom, Vikhroli (West), Mumbai Maharashtra, India, 400079 effective from 01 February 2025. Powered by Capital Market - Live

5 months agoCapital Market - Live
Corporate
Rossari Biotech allots 7,5000 equity shares under ESOP

Rossari Biotech has allotted 7,500 equity shares under ESOP on 21 January 2025. Consequently, the paid up equity share capital has increased to Rs. 11,07,27,532 consisting of 55363766 equity shares of Rs. 2/- each.Powered by Capital Market - Live

5 months agoCapital Market - Live

Frequently asked questions

Frequently asked questions

  1. What is the share price of Rossari Biotech Ltd (ROSSARI) today?

    The share price of ROSSARI as on 10th July 2025 is ₹700.60. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.

  2. What is the return on Rossari Biotech Ltd (ROSSARI) share?

    The past returns of Rossari Biotech Ltd (ROSSARI) share are
    • Past 1 week: 5.07%
    • Past 1 month: 2.15%
    • Past 3 months: 2.03%
    • Past 6 months: -14.52%
    • Past 1 year: -14.11%
    • Past 3 years: -18.23%
    • Past 5 years: -5.53%

  3. What are the peers or stocks similar to Rossari Biotech Ltd (ROSSARI)?
  4. What is the dividend yield % of Rossari Biotech Ltd (ROSSARI) share?

    The current dividend yield of Rossari Biotech Ltd (ROSSARI) is 0.07.

  5. What is the market cap of Rossari Biotech Ltd (ROSSARI) share?

    Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Rossari Biotech Ltd (ROSSARI) is ₹3878.98 Cr as of 10th July 2025.

  6. What is the 52 week high and low of Rossari Biotech Ltd (ROSSARI) share?

    The 52-week high of Rossari Biotech Ltd (ROSSARI) is ₹972.70 and the 52-week low is ₹569.

  7. What is the PE and PB ratio of Rossari Biotech Ltd (ROSSARI) stock?

    The P/E (price-to-earnings) ratio of Rossari Biotech Ltd (ROSSARI) is 28.44. The P/B (price-to-book) ratio is 3.27.

  8. Which sector does Rossari Biotech Ltd (ROSSARI) belong to?

    Rossari Biotech Ltd (ROSSARI) belongs to the Materials sector & Specialty Chemicals sub-sector.

  9. How to buy Rossari Biotech Ltd (ROSSARI) shares?

    You can directly buy Rossari Biotech Ltd (ROSSARI) shares on Tickertape. Simply sign up, connect your demat account and place your order.